Queen’s University Belfast:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Queen's University Belfast - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9373
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Queen’s University Belfast (Queen’s University) is an educational institution that offers education and research services. The institute provides undergraduate, professional development and postgraduate programs. Its postgraduate programs comprise postgraduate diploma in nursing, MSc advanced professional and clinical practice, master of philosophy, doctor of philosophy, a postgraduate certificate in non-medical prescribing and doctorate in nursing practice, among others. Queen’s University operates Institutes For Global Food Security, Institutes For Global Peace, Institutes For Security and Justice, Institutes For Electronics, Institutes For Health Sciences, Institutes For Communications and Information Technology, and others. The institute has operations in the UK and Ireland. Queen’s University is headquartered in Belfast, the UK.

Queen’s University Belfast – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Queen’s University Belfast, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Queen’s University Belfast, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Queen’s University Belfast, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Queen’s University Belfast, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Queen’s University Belfast, Medical Devices Deals, 2012 to YTD 2018 9
Queen’s University Belfast, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Queen’s University Belfast, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Queen’s University Belfast Enters into Agreement with Fusion Antibodies 11
CV6 Therapeutics Enters into Partnership with Queen’s University Belfast 12
Almac Discovery Enters Into Agreement With Queen’s University Belfast For Drug Discovery 13
Equity Offering 15
Re-Vana Therapeutics Spin Off from Queen’s University Belfast 15
Causeway Sensors Spin Off from Queens University Belfast 16
Queen’s University Belfast – Key Competitors 17
Queen’s University Belfast – Key Employees 18
Queen’s University Belfast – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Government and Public Interest 20
Sep 06, 2018: Queen’s University researchers discover ground-breaking process which destroys bowel cancer 20
Feb 15, 2018: Queen’s University announces novel drug delivery system with potential to reduce rates of HIV 21
Feb 14, 2018: Belfast scientist awarded £250,000 for heart failure research 22
Oct 26, 2017: £800K Boost for Queen’s University Researchers to Improve Bowel Cancer Treatment 23
May 30, 2017: Queen’s Researchers Make Breakthrough Discovery in Fight Against Bowel Cancer 25
Mar 24, 2017: Study shows potential of stem cell therapy to repair lung damage 27
Product News 28
Feb 09, 2017: International team of researchers develop new model for earlier treatments for AMD 28
Feb 01, 2017: Researchers develop best-yet cell culture system for age-related macular degeneration 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Queen's University Belfast, Pharmaceuticals & Healthcare, Key Facts 2
Queen's University Belfast, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Queen's University Belfast, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Queen's University Belfast, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Queen's University Belfast, Deals By Therapy Area, 2012 to YTD 2018 8
Queen's University Belfast, Medical Devices Deals, 2012 to YTD 2018 9
Queen's University Belfast, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Queen's University Belfast Enters into Agreement with Fusion Antibodies 11
CV6 Therapeutics Enters into Partnership with Queen's University Belfast 12
Almac Discovery Enters Into Agreement With Queen’s University Belfast For Drug Discovery 13
Re-Vana Therapeutics Spin Off from Queen’s University Belfast 15
Causeway Sensors Spin Off from Queens University Belfast 16
Queen's University Belfast, Key Competitors 17
Queen's University Belfast, Key Employees 18

List of Figures
Queen's University Belfast, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Queen's University Belfast, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Queen's University Belfast, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Queen's University Belfast, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Queen's University Belfast, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Queen's University Belfast, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Queen's University Belfast, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Queen's University Belfast, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Queen's University Belfast, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Queen’s University Belfast:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Power Corporation of Canada:企業の戦略・SWOT・財務分析
    Power Corporation of Canada - Strategy, SWOT and Corporate Finance Report Summary Power Corporation of Canada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Unity Biotechnology Inc (UBX):製薬・医療:M&Aディール及び事業提携情報
    Summary Unity Biotechnology Inc (Unity Biotechnology), formerly Forge Inc is a biotechnology company that researches, develops and commercializes therapeutics for the treatment of age-related diseases. The company focuses on the development of senolytic medicines to eliminate senescent cells. The co …
  • Sime Darby Bhd (SIME):企業の財務・戦略的SWOT分析
    Sime Darby Bhd (SIME) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Joincare Pharmaceutical Group Industry Co Ltd (600380):製薬・医療:M&Aディール及び事業提携情報
    Summary Joincare Pharmaceutical Group Industry Co Ltd (Joincare Pharma) is a manufacturer and supplier of pharmaceutical products. The company offers healthcare products, bulk prescription products, active pharmaceutical ingredients, OTC products, detection reagents, and food additives. Its healthca …
  • Microsoft Corporation:企業のM&A・事業提携・投資動向
    Microsoft Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Microsoft Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Ur-Energy Inc. (URE):企業の財務・戦略的SWOT分析
    Ur-Energy Inc. (URE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • DBK Pharmaceutical:製薬・医療:M&Aディール及び事業提携情報
    Summary DBK Pharmaceutical (DBK Pharma) is a pharmaceutical company that develops, manufactures and markets pharmaceutical, herbal brands, food supplements, cosmetics and veterinary products. The company’s pharmaceutical products include chitocal capsule, debeskon, rentensar tablets, pressothioval, …
  • CytomX Therapeutics Inc (CTMX):製薬・医療:M&Aディール及び事業提携情報
    Summary CytomX Therapeutics Inc (CytomX) is a clinical-stage biopharmaceutical company which develops novel therapeutic antibodies and Probody therapeutics for the treatment of cancer. The company’s leading product candidates include CX-072, CX-2009, BMS-986249, CX-2029, CX-188, probody drug conjuga …
  • Norsk Hydro ASA (NHY)-エネルギー分野:企業M&A・提携分析
    Summary Norsk Hydro ASA (Hydro) is a global supplier of aluminum and an electricity producer. Its operations span the value chain, from bauxite extraction to the production of rolled and extruded aluminum products and building systems. Its portfolio of products include bauxite, alumina, extrusion in …
  • SmarTone Telecommunications Holdings Ltd (315):企業の財務・戦略的SWOT分析
    SmarTone Telecommunications Holdings Ltd (315) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • 3M Co (MMM):医療機器:M&Aディール及び事業提携情報
    Summary 3M Company (3M) is a diversified technology company that specializes in the development, manufacture and marketing of a wide range of innovative products. The company develops technology platforms, including adhesives, abrasives, light management, microreplication, non woven materials, nanot …
  • Hotel Leela Venture Limited:戦略・SWOT・企業財務分析
    Hotel Leela Venture Limited - Strategy, SWOT and Corporate Finance Report Summary Hotel Leela Venture Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Xenetic Biosciences Inc (XBIO)-製薬・医療分野:企業M&A・提携分析
    Summary Xenetic Biosciences Inc (Xenetic), formerly General Sales & Leasing, Inc., is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of biologic drugs and innovative orphan cancer drugs. The company’s pipeline products include ErepoXen, Virexxa and OncoHis …
  • Otrum AS:企業の戦略的SWOT分析
    Otrum AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Telormedix SA-製薬・医療分野:企業M&A・提携分析
    Summary Telormedix SA (Telormedix) is a biopharmaceutical company. The company develops and provides immune drugs for the treatment of cancer and other infectious diseases. It offers products such as TMX-201, TMX-202 and vesimune (TMX-101). Its vesimune (TMX-101) provides treatment for superficial b …
  • Ewopharma AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Ewopharma AG (Ewopharma) is a pharmaceutical company that provides registration and marketing of pharmaceuticals and consumer health products. The company provides services such as market evaluation, marketing services, regulatory affairs, licensing, pharmacovigilance, and others. It offers …
  • Inmarsat Plc (ISAT):企業の財務・戦略的SWOT分析
    Inmarsat Plc (ISAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Insightra Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Insightra Medical Inc (Insightra Medical), a subsidiary of GPB Life Science Holdings LLC is a medical device company that develops disposable devices. The company provides cardiovascular and surgical solutions. It offers cardiovascular solutions such as Ultra 7FR IAB and modulare. The Modula …
  • Brambles Limited:企業の戦略・SWOT・財務分析
    Brambles Limited - Strategy, SWOT and Corporate Finance Report Summary Brambles Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • AmerisourceBergen Corp (ABC):医療機器:M&Aディール及び事業提携情報
    Summary AmerisourceBergen Corp (AmerisourceBergen) is a pharmaceutical sourcing and distribution services company. It offers a wide range of services ranging from drug distribution to manufacturer solutions including niche premium logistics services, reimbursement and pharmaceutical consulting servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆